بررسی تأثیر مصرف مکمل اسید لینولئیک مزدوج بر ترکیب بدن

نوع مقاله : مقاله مروری

نویسندگان

1 کارشناس ارشد، گروه علوم بهداشتی در تغذیه، معاونت بهداشتی، دانشگاه علوم پزشکی زاهدان، زاهدان، ایران

2 دانشیار، مرکز تحقیقات امنیت غذایی، گروه تغذیه‌ی جامعه، دانشکده‌ی تغذیه و علوم غذایی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران

چکیده

مقدمه: اسید لینولئیک مزدوج (CLA یا Conjugated linoleic acids) به گروهی از ایزومرهای اسید لینولئیک (18:2) که یک اسید چرب ضروری است، اطلاق می‌شود. به نظر می‌رسد اسید لینولئیک مزدوج یک مکمل رژیمی برای کاهش وزن و چربی بدن می‌باشد. مطالعه‌ی حاضر با هدف بررسی تأثیر مصرف این مکمل بر ترکیب بدن انجام شد.روش‌ها: ابتدا از پایگاه‌های Pubmed و SID مقالاتی که در عنوان خود دارای یکی از کلمات Conjugated linoleic acid، Body composition، Adipose tissue، Lean body mass، BMI، Obesity، Weight retention و Free fatty acid بودند، انتخاب شدند و در نهایت 22 مقاله مورد بررسی قرار گرفتند.یافته‌ها: مطالعات متعدد نشان دادند که مکمل اسید لینولئیک مزدوج سبب کاهش وزن و کاهش توده‌ی چربی در کوتاه مدت در انسان می‌شود و در مورد اثرات مصرف طولانی مدت مکمل اسید لینولئیک مزدوج بر ترکیب بدن، نتایج متفاوتی به دست آمده است. مطالعات انجام شده بر ترکیب بدن از نظر دوز مصرفی اسید لینولئیک مزدوج، طول مدت مطالعه، افراد شرکت کننده در مطالعه، فعالیت فیزیکی، نمایه‌ی توده‌ی بدنی (طبیعی، اضافه وزن و درجه‌های متفاوت چاقی)، گروه سنی، تعداد افراد شرکت کننده، پذیرش کپسول‌ها و نوع ایزومرهای اسید لینولئیک مزدوج متنوع بودند. به نظر می‌رسد ایزومر 10t،12c از بین ایزومرهای مختلف اسید لینولئیک مزدوج سبب تغییرات بهتری در ترکیب بدن می‌شود.نتیجه‌گیری: نتایج حاصل از مطالعات بالینی در مورد اثرات اسید لینولئیک مزدوج بر روی وزن و ترکیب بدن انسان متناقض است. پیشنهاد می‌گردد مطالعات طولانی مدت برای دیدن اثرات مصرف مکمل اسید لینولئیک مزدوج بر ترکیب بدن انجام شود. 

کلیدواژه‌ها

عنوان مقاله [English]

The Effect of Supplementation with Conjugated Linoleic Acid on Body Composition

نویسندگان [English]

  • Mahdiye Sheykhi 1
  • Leila Azadbakht 2
1 Department of Public Health in Nutrition, Health Deputy, Zahedan University of Medical Sciences, Zahedan, Iran
2 Associate Professor, Food Security Research Center AND Department of Community Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
چکیده [English]

Background: Conjugated linoleic acid (CLA) is defined as isomers of linoleic acid group (18:2), which is an essential fatty acid. It seems that conjugated linoleic acid supplementation reduces body weight and fat mass. The aim of the present study was to investigate the effect of supplementation with conjugated linoleic acid on body composition.Methods: We used PubMed and SID search engine to find articles which were contained the following keywords: Conjugated linoleic acid, Body composition, Adipose tissue, Lean Body mass, BMI, Obesity, Weight retention, and Free fatty acid. After the search, 22 articles were recruited and reviewed.Findings: Several studies showed that supplementation of conjugated linoleic acid reduced body weight and fat mass in the short term in humans and long-term effects of this supplementation on body composition were inconsistent. Previous studies were diverted on body composition, dosage of conjugated linoleic acid, the period of the study, participants, physical activity, body mass index (normal, overweight and obesity in different degrees), age group, number of participants, capsule acceptance, and type of the conjugated linoleic acid isomers. It seemed that c12, t10 isomer caused a better change in body composition.Conclusion: The results of clinical studies on the effects of conjugated linoleic acid on weight and body composition are inconsistent. For see better effect of supplementation with conjugated linoleic acid on body composition, long-term studies are needed.

کلیدواژه‌ها [English]

  • Conjugated linoleic acid
  • Body composition
  • Lean body mass
  • Adipose tissue

مراجع

  1. Aydin R. Conjugated linoleic acid: chemical structure, sources and biological properties. Turk J Vet Anim Sci 2005; 29: 189-95.
  2. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 2001; 40(4): 283-98.
  3. Fritsche S, Fritsche J. Occurrence of conjugated linoleic acid isomers in beef. J Amer Oil Chem Soc 1998; 75(10): 1449-51.
  4. Collomb M, Schmid A, Sieber R, Wechsler D, Ryhanen EL. Conjugated linoleic acids in milk fat: Variation and physiological effects. International Dairy Journal 2006; 16(11): 1347-61.
  5. Schmid A, Collomb M, Sieber R, Bee G. Conjugated linoleic acid in meat and meat products: A review. Meat Sci 2006; 73(1): 29-41.
  6. Chin SF, Liu W, Storkson JM, Ha YL, Pariza MW. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. Journal of Food Composition and Analysis 1992; 5(3): 185-97.
  7. Jiang J, Wolk A, Vessby B. Relation between the intake of milk fat and the occurrence of conjugated linoleic acid in human adipose tissue. Am J Clin Nutr 1999; 70(1): 21-7.
  8. Asgary S, Nazari B, Sarrafzadegan N, Parkhideh S, Saberi S, Esmaillzadeh A, et al. Evaluation of fatty acid content of some Iranian fast foods with emphasis on trans fatty acids. Asia Pac J Clin Nutr 2009; 18(2): 187-92.
  9. Asgary S, Nazari B, Sarrafzadegan N, Saberi S, Azadbakht L, Esmaillzadeh A. Fatty acid composition of commercially available Iranian edible oils. J Res Med Sci 2009; 14(4): 211-5.
  10. Esmaillzadeh A, Azadbakht L. Home use of vegetable oils, markers of systemic inflammation, and endothelial dysfunction among women. Am J Clin Nutr 2008; 88(4): 913-21.
  11. Esmaillzadeh A, Azadbakht L. Consumption of hydrogenated versus nonhydrogenated vegetable oils and risk of insulin resistance and the metabolic syndrome among Iranian adult women. Diabetes Care 2008; 31(2): 223-6.
  12. Esmaillzadeh A, Azadbakht L. Different kinds of vegetable oils in relation to individual cardiovascular risk factors among Iranian women. Br J Nutr 2011; 105(6): 919-27.
  13. Wallace RJ, McKain N, Shingfield KJ, Devillard E. Isomers of conjugated linoleic acids are synthesized via different mechanisms in ruminal digesta and bacteria. J Lipid Res 2007; 48(10): 2247-54.
  14. Dhiman TR, Nam SH, Ure AL. Factors affecting conjugated linoleic acid content in milk and meat. Crit Rev Food Sci Nutr 2005; 45(6): 463-82.
  15. Silveira MB, Carraro R, Monereo S, Tebar J. Conjugated linoleic acid (CLA) and obesity. Public Health Nutr 2007; 10(10A): 1181-6.
  16. Mendis S, Cruz-Hernandez C, Ratnayake WM. Fatty acid profile of Canadian dairy products with special attention to the trans-octadecenoic acid and conjugated linoleic acid isomers. J AOAC Int 2008; 91(4): 811-9.
  17. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999; 34(3): 235-41.
  18. Gavino VC, Gavino G, Leblanc MJ, Tuchweber B. An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr 2000; 130(1): 27-9.
  19. Ha YL, Storkson J, Pariza MW. Inhibition of benzo(a)pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acid. Cancer Res 1990; 50(4): 1097-101.
  20. Ha YL, Grimm NK, Pariza MW. Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 1987; 8(12): 1881-7.
  21. Ip C, Chin SF, Scimeca JA, Pariza MW. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res 1991; 51(22): 6118-24.
  22. Liew C, Schut HA, Chin SF, Pariza MW, Dashwood RH. Protection of conjugated linoleic acids against 2-amino-3- methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 1995; 16(12): 3037-43.
  23. Belury MA. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 2002; 132(10): 2995-8.
  24. Belury MA, Nickel KP, Bird CE, Wu Y. Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer 1996; 26(2): 149-57.
  25. Ip MM, Masso-Welch PA, Shoemaker SF, Shea-Eaton WK, Ip C. Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 1999; 250(1): 22-34.
  26. Ip C, Banni S, Angioni E, Carta G, McGinley J, Thompson HJ, et al. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr 1999; 129(12): 2135-42.
  27. Ryder JW, Portocarrero CP, Song XM, Cui L, Yu M, Combatsiaris T, et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 2001; 50(5): 1149-57.
  28. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 1998; 244(3): 678-82.
  29. Yang M, Cook ME. Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production. Exp Biol Med (Maywood) 2003; 228(1): 51-8.
  30. Yu Y, Correll PH, Vanden Heuvel JP. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta 2002; 1581(3): 89-99.
  31. Iwakiri Y, Sampson DA, Allen KG. Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Prostaglandins Leukot Essent Fatty Acids 2002; 67(6): 435-43.
  32. Miller CC, Park Y, Pariza MW, Cook ME. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun 1994; 198(3): 1107-12.
  33. Larsen TM, Toubro S, Gudmundsen O, Astrup A. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr 2006; 83(3): 606-12.
  34. Wang YW, Jones PJ. Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 2004; 28(8): 941-55.
  35. Poirier H, Shapiro JS, Kim RJ, Lazar MA. Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes 2006; 55(6): 1634-41.
  36. Gaullier JM, Halse J, Hoivik HO, Hoye K, Syvertsen C, Nurminiemi M, et al. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. Br J Nutr 2007; 97(3): 550-60.
  37. Belury MA, Mahon A, Banni S. The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J Nutr 2003; 133(1): 257S-60S.
  38. Simon E, Macarulla MT, Churruca I, Fernandez-Quintela A, Portillo MP. trans-10,cis-12 conjugated linoleic acid prevents adiposity but not insulin resistance induced by an atherogenic diet in hamsters. J Nutr Biochem 2006; 17(2): 126-31.
  39. Riserus U, Vessby B, Arnlov J, Basu S. Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 2004; 80(2): 279-83.
  40. Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc 2004; 36(5): 814-20.
  41. Noto A, Zahradka P, Ryz NR, Yurkova N, Xie X, Taylor CG. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats. Metabolism 2007; 56(1): 142-51.
  42. de RB, Rucklidge G, Reid M, Ross K, Duncan G, Navarro MA, et al. Divergent mechanisms of cis9, trans11-and trans10, cis12-conjugated linoleic acid affecting insulin resistance and inflammation in apolipoprotein E knockout mice: a proteomics approach. FASEB J 2005; 19(12): 1746-8.
  43. Miner JL, Cederberg CA, Nielsen MK, Chen X, Baile CA. Conjugated linoleic acid (CLA), body fat, and apoptosis. Obes Res 2001; 9(2): 129-34.
  44. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 2000; 49(9): 1534-42.
  45. West DB, Blohm FY, Truett AA, DeLany JP. Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J Nutr 2000; 130(10): 2471-7.
  46. Wilson TA, Nicolosi RJ, Chrysam M, Kritchevsky D. Conjugated linoleic acid reduces early aortic atherosclerosis greater than linoleic acid in hypercholesterolemic hamsters. Nutrition Research20(12): 1795-805.
  47. Nicolosi RJ, Rogers EJ, Kritchevsky D, Scimeca JA, Huth PJ. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 1997; 22(5): 266-77.
  48. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000; 130(12): 2943-8.
  49. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004; 79(6): 1118-25.
  50. Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord 2001; 25(8): 1129-35.
  51. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans--metabolic effects. Lipids 2001; 36(8): 773-81.
  52. Watras AC, Buchholz AC, Close RN, Zhang Z, Schoeller DA. The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int J Obes (Lond) 2007; 31(3): 481-7.
  53. Pinkoski C, Chilibeck PD, Candow DG, Esliger D, Ewaschuk JB, Facci M, et al. The effects of conjugated linoleic acid supplementation during resistance training. Med Sci Sports Exerc 2006; 38(2): 339-48.
  54. Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, et al. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. J Nutr 2007; 137(5): 1188-93.
  55. Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 2001; 29(5): 392-6.
  56. Park Y, Pariza MW. Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Research International 2007; 40(3): 311-23.
  57. Kennedy A, Martinez K, Schmidt S, Mandrup S, LaPoint K, McIntosh M. Antiobesity mechanisms of action of conjugated linoleic acid. J Nutr Biochem 2010; 21(3): 171-9.
  58. Brown JM, McIntosh MK. Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity. J Nutr 2003; 133(10): 3041-6.
  59. Berven G, Bye A, Hals O, Blankson H, Fagertun H, Thom E, et al. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol 2000; 102(7): 455-62.
  60. Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002; 25(9): 1516-21.
  61. Whigham LD, Cook ME, Atkinson RL. Conjugated linoleic acid: implications for human health. Pharmacol Res 2000; 42(6): 503-10.
  62. Kreider RB, Ferreira MP, Greenwood M, Wilson M, Almada AL. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res 2002; 16(3): 325-34.
  63. Petridou A, Mougios V, Sagredos A. Supplementation with CLA: isomer incorporation into serum lipids and effect on body fat of women. Lipids 2003; 38(8): 805-11.
  64. Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. Conjugated linoleic acid impairs endothelial function. Arterioscler Thromb Vasc Biol 2006; 26(2): 307-12.
  65. Clement L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, et al. Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 2002; 43(9): 1400-9.
  66. Martin JC, Valeille K. Conjugated linoleic acids: all the same or to everyone its own function? Reprod Nutr Dev 2002; 42(6): 525-36.
  67. Gaullier JM, Berven G, Blankson H, Gudmundsen O. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids 2002; 37(11): 1019-25.
  68. Basu S, Riserus U, Turpeinen A, Vessby B. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci (Lond) 2000; 99(6): 511-6.
  69. Zambell KL, Keim NL, Van Loan MD, Gale B, Benito P, Kelley DS, et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 2000; 35(7): 777-82.
  70. Whigham LD, Watras AC, Schoeller DA. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 2007; 85(5): 1203-11.
  71. Baddini FA, Fernandes PA, Ferreira da CN, Goncalves RB. Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile. Nutr Hosp 2009; 24(4): 422-8.
  72. Salas-Salvado J, Marquez-Sandoval F, Bullo M. Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 2006; 46(6): 479-88.
  73. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 2003; 27(7): 840-7.
  74. Tavakkoli Darestani A, Hosseinpanah FA, Tahbaz F, Amiri Z, Tavakkoli Darestani R, Hedayati M. Effects of conjugated linoleic acid supplementation on body composition and leptin concentration in post-menopausal women. IJEM 2010; 12(1): 48-59. [In Persian].
  75. Onakpoya IJ, Posadzki PP, Watson LK, Davies LA, Ernst E. The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials. Eur J Nutr 2012; 51(2): 127-34.
  76. Joseph SV, Jacques H, Plourde M, Mitchell PL, McLeod RS, Jones PJ. Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. J Nutr 2011; 141(7): 1286-91.
  77. Liu X, Joseph SV, Wakefield AP, Aukema HM, Jones PJ. High dose trans-10,cis-12 CLA increases lean body mass in hamsters, but elevates levels of plasma lipids and liver enzyme biomarkers. Lipids 2012; 47(1): 39-46.
مجله دانشکده پزشکی اصفهان
دوره 32، شماره 305 - شماره پیاپی 305
آذر و دی 1393
صفحه 1728-1738

فایل ها

سابقه مقاله

  • تاریخ دریافت: 20 اسفند 1392
  • تاریخ بازنگری: 11 آبان 1403
  • تاریخ پذیرش: 17 فروردین 1401

هم رسانی

ارجاع به این مقاله

آمار